Home 5 Clinical Diagnostics Insider 5 GAO: FDA Needs Policy to Avoid Repeating EUA COVID-19 Test Mistakes

GAO: FDA Needs Policy to Avoid Repeating EUA COVID-19 Test Mistakes

by | Jul 20, 2022 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet

In a recent report, the GAO says the agency needs a policy when it comes to enforcement discretion regarding tests approved via EUA.

Sign up for our free weekly Lab & Pathology Insider email newsletter

Subscribe to Clinical Diagnostics Insider to view

Start a Free Trial for immediate access to this article